Newsletter | February 28, 2019

02.28.19 -- Innovative Learning Events And Opportunities

 
Featured Event
DIA 2019 Global Annual Meeting
 

June 23 to 27, 2019 | San Diego, CA

The DIA 2019 Global Annual Meeting is where innovation meets excellence. It’s where brilliant minds in the life sciences come together to engage in discussions on today’s hottest topics, explore solutions to the challenges that arise in this ever-changing field, and ultimately find ways to better patient lives.

Learning Opportunities


Medical Affairs And Scientific Communications Forum
March 18-20 | Orlando, FL
This forum provides a comprehensive understanding of the regulatory and compliance environment directly affecting the daily activities of medical affairs and scientific communication professionals.

 

DIA/FDA Biostatistics Industry And Regulator Forum
April 8-10 | North Bethesda, MD
Focus on statistical thinking to inform policy, regulation, development, and review of medical products in the context of the current scientific and regulatory environments including pharmaceuticals, biologics and biosimilars, combination products and devices, and generics.

 

Drug Safety And Pharmacovigilance Across The Product Lifecycle
April 8-10 | North Bethesda, MD
Explore contemporary principles, regulatory expectations, and practical approaches to drug safety and pharmacovigilance in key regulatory jurisdictions, with a focus on the US and EU.

 

Regulatory Affairs: The IND, NDA, And Post-Marketing
April 8-11 | North Bethesda, MD
Learn about FDA regulations and expectations for the content, submission and review of INDs/NDAs, and the importance of regulatory strategy.

 

CMC Workshop
April 23-25 | North Bethesda, MD
Explore how to utilize effective CMC strategies and execution and how it can help to reduce regulatory burden, enable shorter review timelines, and support post-approval maintenance.

 

Clinical Statistics For Nonstatisticians
April 29-30 | New Haven, CT
This course will increase the level of statistical knowledge of nonstatisticians so that collaborative efforts of statisticians and nonstatisticians on clinical investigative teams can be improved.

 

Drug Safety And Pharmacovigilance Across The Product Lifecycle
August 12-14 | Boston, MA
Explore contemporary principles, regulatory expectations, and practical approaches to drug safety and pharmacovigilance in key regulatory jurisdictions, with a focus on the US and EU.

 

Regulatory Affairs: The IND, NDA, And Post-Marketing
August 12-15 | Boston, MA
Learn about FDA regulations and expectations for the content, submission and review of INDs/NDAs, and the importance of regulatory strategy.

 

Navigating Chemistry, Manufacturing, And Controls Through The Drug Development Process
August 12-13 | Boston, MA
This course will allow you to apply several of the principals learned to real-life situations and to arm yourself with the tools to write and/or assemble CMC sections of regulatory submissions, prepare for and orchestrate CMC meetings with FDA, and provide a clear understanding on how to avoid noncompliance.

 

New Drug Product Development And Lifecycle Management
August 12-13 | Boston, MA
Discuss the phases, major workstreams, key players, and interrelationships necessary to develop new drugs in the US and Europe and to expand the lifecycle of in-line products.

 

The Pharmacovigilance Quality Management System
August 15-16 | Boston, MA
Learn contemporary principles, practical approaches, and regulatory expectations for the Pharmacovigilance Quality Management System.

 

Drug Safety eLearning Program
Online
The Drug Safety eLearning Program provides the knowledge you need, from regulations and requirements through pre-market review and post-market monitoring. This comprehensive program includes six self-paced modules that have been designed using the latest instructional strategies including microlearning and gamification to improve retention and make learning convenient for busy professionals.